Benefit of Tin Filter in Regards to Image Quality and Radiation Dose in CT Scan Study of Pulmonary Parenchyma

October 4, 2019 updated by: Ramsay Générale de Santé

Benefit of Tin Filter in Regards to Image Quality and Radiation Dose in CT Scan

Main objective: to demonstrate that the diagnostic quality associated with the acquisition mode with tin filter, evaluated in a subjective way, is not inferior to that associated with the acquisition mode without filter.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The chest x-ray is the first-line exam for the study of pulmonary parenchyma. Nevertheless, it does not make it possible to reveal all pulmonary pathologies, and in particular those of very small sizes. Thanks to its very high spatial resolution and contrast resolution, the scanner is able to detect all infra-millimetric pathologies of the pulmonary parenchyma but also mediastinal pathologies that could not have been seen on the standard x-ray.

This study fits into the context of pleural pathology screening for patients exposed to asbestos in their professional environment.

Today, the chest CT scan in millimetric sections isth e standardised method used in the context of this screening.Tin filtration is an additional filtration at the output of the X-ray tube made available on premium Siemens scanners. In diagnostic medical imaging, the photon beam has an energetic spectrum ranging from 0 to 150 keV. However the weak energies do not participate in the formation of the image but, on the other hand, to the overall radiation of the patient. The purpose of the addition of the tin filter is to be able to suppress, at the output of the tube, all low and medium energy levels, only allowing high energy levels to pass through. A previous study comparing the same group of patients on two different machines (one with tin filtration, one without tin filtration) showed a significant decrease in the radiation dose; nevertheless, a certain number of parameters differed between the two scanners used. In order to get rid of the different biases encountered on previous published studies, we propose to carry out this study on the same machine, by activating and deactivating tin filtration, all other parameters of acquisition and reconstruction of the image being equal in all respects.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • IDF
      • Antony, IDF, France, 92160
        • Recruiting
        • Hôpital Privé d'Antony Antony

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient aged 18 and over.
  • Patient referred for chest CT scan in the context of screening or monitoring of occupational exposure to asbestos.
  • Patient with health insurance or beneficiary of a social security scheme.
  • Patient having given their express consent.

Exclusion Criteria:

  • Woman who is pregnant or likely to be pregnant.
  • Lactating or parturient women
  • Minors.
  • Protected patients: Adults under trusteeship, guardianship or other legal protection, deprived of liberty by judicial or administrative decision; hospitalised without consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Arm
the first acquisition will be carried out without a tin filter in supine position and the second with tin filter in procubitus.

Acquisition:

  • 140 kVp,
  • 1/2 mAs/kg,
  • Pitch: 1.35,
  • Rotation time: 0.5 sec.

Reconstruction:

  • I70f filter, 3 iteration loops,
  • Cutting thickness 1 mm/0.7 mm
  • Fenestration: C -600/W 1600
  • Field of view (Size, x & y coordinates) identical on both acquisitions.
Experimental: Tin filter Arm
the first acquisition will be carried out with tin filter in supine position and the second without tin filter in procubitus.

Acquisition:

  • 140 kVp,
  • 1/2 mAs/kg,
  • Pitch: 1.35,
  • Rotation time: 0.5 sec.

Reconstruction:

  • I70f filter, 3 iteration loops,
  • Cutting thickness 1 mm/0.7 mm
  • Fenestration: C -600/W 1600
  • Field of view (Size, x & y coordinates) identical on both acquisitions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Likert score scale score
Time Frame: 1 hour
Primary endpoint: score obtained on the Likert scale.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2019

Primary Completion (Anticipated)

June 30, 2020

Study Completion (Anticipated)

June 30, 2020

Study Registration Dates

First Submitted

October 3, 2019

First Submitted That Met QC Criteria

October 4, 2019

First Posted (Actual)

October 8, 2019

Study Record Updates

Last Update Posted (Actual)

October 8, 2019

Last Update Submitted That Met QC Criteria

October 4, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-A00918-47

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tin X Ray

Clinical Trials on X ray imaging

3
Subscribe